Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20355)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | GR50 | GRmax | GR_AOC | GEC50 | GRinf | GR Hill Coefficient | GR r2 | pval_GR |
---|---|---|---|---|---|---|---|---|---|
MCF 10A | GSK2334470 | 15.0731115613 | 0.8830 | -0.0129 | 18.7770 | -1.0000 | 5.0000 | 0.4636 | 0.000172093714918 |
SUM159PT | Senexin B | inf | 0.9016 | 0.0793 | 0.0000 | 0.9165 | 0.0100 | 0.0000 | 0.292587245 |
BT-549 | Ribociclib | inf | 0.9258 | 0.0097 | 0.0000 | 0.9885 | 0.0100 | 0.0000 | 0.489440623384 |
MDA-MB-231 | SHP099 | inf | 0.9470 | -0.0146 | 0.0000 | 1.0000 | 0.0100 | -0.0002 | 0.198394332856 |
CAL-85-1 | Ribociclib | inf | 0.9479 | 0.1502 | 0.0000 | 0.8929 | 0.0100 | 0.0000 | 1.0 |
MDA-MB-436 | Ribociclib | inf | 0.9493 | -0.0090 | 0.0000 | 1.0000 | 0.0100 | -0.0149 | 0.928505437 |
HCC1806 | SHP099 | inf | 0.9525 | -0.0087 | 0.0000 | 1.0000 | 0.0100 | -0.0671 | 0.950463130981 |
AU565 | SHP099 | inf | 0.9751 | 0.0242 | 0.0000 | 0.9633 | 0.0100 | 0.0000 | 1.0 |
HCC1937 | Ribociclib | inf | 0.9905 | -0.0141 | 0.0000 | 0.9898 | 0.0100 | 0.0000 | 1.0 |
HCC1500 | AZD5363 | -inf | 0.9937 | ||||||
SK-BR-3 | SHP099 | inf | 0.9987 | 0.0260 | 0.0000 | 0.9879 | 0.0100 | 0.0000 | 1.0 |
HCC1500 | Ribociclib | inf | 1.0336 | 0.4512 | 0.0000 | 0.5131 | 0.0100 | 0.0000 | 1.0 |
HCC70 | Ribociclib | inf | 1.0564 | -0.0040 | 0.0000 | 1.0000 | 0.0100 | -0.1699 | 1.0 |
HCC1500 | Rucaparib | #NAME? | 1.0742 | 0.0000 | 0.1000 | 0.0100 | |||
MDA-MB-231 | AZD5363 | inf | 1.0802 | -0.0194 | 0.0000 | 1.0000 | 0.0100 | -0.2298 | 1.0 |
HCC70 | Rucaparib | inf | 1.1144 | -0.0414 | 0.0000 | 1.0000 | 0.0100 | -0.1078 | 1.0 |
HCC1428 | AZD5363 | inf | 1.8797 | -0.1143 | 0.0000 | 1.0000 | 0.0100 | -0.2534 | 1.0 |
MDA-MB-436 | AZD6738 | -inf | |||||||
Hs 578T | BMS-265246 | -inf |